MCRB

NASD Seres Therapeutics Inc
Oct 2, 2026 · 11:46 AM ET DELAYED Market Open

$2.95 ↑ +0.02 (+0.68%) Trading Up from the previous close of $2.93, $0.25 below the day’s high of $3.20

YTD change
-80.17%
vs 20-day SMA
-31.59%
vs 200-day SMA
-65.16%

Price ranges

Previous day
$2.83 $3.41
open $3.10 close $2.93
-$0.17 (-5.48%)
Today
$2.95 $3.20
open $2.98 now $2.95
-$0.03 (-1.01%)
Past week
$2.83 $3.70
from $3.62 now $2.95
-$0.67 (-18.51%)
Past month
$2.83 $5.95
from $5.54 now $2.95
-$2.59 (-46.75%)
This year
$2.83 $16.42
from $14.88 now $2.95
-$11.93 (-80.17%)

Price & Performance

-6.34 (-68.39%) / 6M

$2.42$4.87$7.33$9.78Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.6% away from all-time highs of $770.00
  • MCRB is down 80% since the beginning of the year
  • MCRB is down 86% over the past 12 months
  • MCRB is down 47% over the past 1 month
  • 3% of all MCRB investors are betting against MCRB

MCRB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -86.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.47
Earnings momentum +146.8% Quarterly EPS growth
Quarterly change +146.8%

Valuation

P/E ratio N/A
Enterprise value $69.6M
Beta 0.63

Balance sheet & scale

IncomeN/A
Revenue$1.9M
Cash$15.6M
Debt$56.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $29.3M

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.27 -3.38%
MRNA Moderna, Inc. $188.94 -1.89%
RVMD Revolution Medicines, Inc. $205.89 +0.31%
ROIV Roivant Sciences Ltd. $35.50 -2.93%
BNTX BioNTech SE Sponsored ADR $96.85 -1.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.